News

Shares of DexCom Inc. DXCM rose 5.86% to $70.78 Thursday, on what proved to be an all-around positive trading session for the ...
San Diego-based Dexcom, a leading diabetes technology company known for its wearable glucose monitors, is expanding its NIL ...
Shares of DexCom Inc. DXCM slid 3.59% to $66.11 Monday, on what proved to be an all-around rough trading session for the ...
SAN DIEGO, April 22, 2025--DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today the return of Dexcom U – its one-of-a-kind Name, Image and Likeness program ...
SAN DIEGO – Dexcom is bringing back Dexcom U, a name, image and license program for college athletes with diabetes.
What Johnson & Johnson and Eli Lilly are saying about Trump’s pharmaceutical tariffs, and Dexcom scores FDA approval for its ...
DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today the return of Dexcom U – its ...
The FDA has cleared the Dexcom G7 15 Day continuous glucose monitoring system for individuals 18 years and older with diabetes.
In a head-to-head study, three continuous glucose monitoring systems showed different measurements in the same person, which ...
If you're using a Dexcom G7 to monitor your blood sugar in real-time, you can now sync it to your Apple Watch for real-time ...
Mark Andrews breaks silence on playoff drop at fund raiser for his new NIL fund dedicated to athletes with diabetes.
Peter Loftus is a reporter for The Wall Street Journal in Philadelphia covering the pharmaceutical and medical-device ...